Screener
Sabra Healthcare SBRA Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Sabra Healthcare in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.
The source filing: Sabra Healthcare’s 10-Q, filed April 29, 2026.
- Filed
- Apr 29, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001492298-26-000012
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Issuance of common stock, net | (8,247) | (5,391) |
| Dividends paid on common stock | (75,657) | (71,373) |
| Net cash provided by (used in) financing activities | 52,099 | (101,242) |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 45,371 | (37,423) |
| Effect of foreign currency translation on cash, cash equivalents and restricted cash | (60) | (19) |
| Cash, cash equivalents and restricted cash, beginning of period | 78,140 | 66,339 |
| Cash, cash equivalents and restricted cash, end of period | $123,451 | $28,897 |
| Supplemental disclosure of cash flow information: |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Sabra Healthcare's net change in cash?
- Sabra Healthcare (SBRA) reported net change in cash of $45.37M in Q1 2026.
- How has Sabra Healthcare's net change in cash changed year-over-year?
- Sabra Healthcare's net change in cash increased by 221.2% year-over-year, from -$37.42M to $45.37M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Sabra Healthcare's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude